State-of-the-art in radiomics of hepatocellular carcinoma: a review of basic principles, applications, and limitations

Imagem de Miniatura
Arquivos
art_SANTOS_Stateoftheart_in_radiomics_of_hepatocellular_carcinoma_a_review_2020.PDF (1000.04 KB)
Citações na Scopus
42
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
ARAUJO-FILHO, Jose de Arimateia Batista
ASSUNCAO- JR., Antonildes N.
MACHADO, Felipe Augusto de M.
Citação
ABDOMINAL RADIOLOGY, v.45, n.2, p.342-353, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Radiomics is a new field in medical imaging with the potential of changing medical practice. Radiomics is characterized by the extraction of several quantitative imaging features which are not visible to the naked eye from conventional imaging modalities, and its correlation with specific relevant clinical endpoints, such as pathology, therapeutic response, and survival. Several studies have evaluated the use of radiomics in patients with hepatocellular carcinoma (HCC) with encouraging results, particularly in the pretreatment prediction of tumor biological characteristics, risk of recurrence, and survival. In spite of this, there are limitations and challenges to be overcome before the implementation of radiomics into clinical routine. In this article, we will review the concepts of radiomics and their current potential applications in patients with HCC. It is important that the multidisciplinary team involved in the treatment of patients with HCC be aware of the basic principles, benefits, and limitations of radiomics in order to achieve a balanced interpretation of the results toward a personalized medicine.
Palavras-chave
Hepatocellular carcinoma, Radiomics, Textural analysis, Liver neoplasms, Magnetic resonance imaging, Computed tomography, Positron emission tomography
URI
https://observatorio.fm.usp.br/handle/OPI/39147
Referências
  1. Akai H, 2018, DIAGN INTERV IMAG, V99, P643, DOI 10.1016/j.diii.2018.05.008
  2. Bakr S, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.4.041303
  3. Bashir U, 2016, AM J ROENTGENOL, V207, P534, DOI 10.2214/AJR.15.15864
  4. Blanc-Durand P, 2018, ONCOTARGET, V9, P4549, DOI 10.18632/oncotarget.23423
  5. Cai W, 2019, SURG ONCOL, V28, P78, DOI 10.1016/j.suronc.2018.11.013
  6. Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953
  7. Cruite I, 2013, AM J ROENTGENOL, V201, P41, DOI 10.2214/AJR.13.10570
  8. Duan N, 2020, EUR RADIOL, V30, P1054, DOI 10.1007/s00330-019-06434-y
  9. El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2
  10. Fan ST, 1999, ANN SURG, V229, P322, DOI 10.1097/00000658-199903000-00004
  11. Fehr D, 2015, P NATL ACAD SCI USA, V112, pE6265, DOI 10.1073/pnas.1505935112
  12. Feng ST, 2019, EUR RADIOL
  13. Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
  14. Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169
  15. Guo DH, 2019, EUR J RADIOL, V117, P33, DOI 10.1016/j.ejrad.2019.05.010
  16. Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db
  17. Horvat N, 2019, NOVEL IMAGING TECHNI
  18. Horvat N, 2019, ABDOM RADIOL NY
  19. Horvat N, 2018, RADIOL ONCOL, V52, P353, DOI 10.2478/raon-2018-0044
  20. Horvat N, 2018, ABDOM RADIOL, V43, P169, DOI 10.1007/s00261-017-1261-x
  21. Hui TCH, 2018, CLIN RADIOL, V73, DOI 10.1016/j.crad.2018.07.109
  22. Imamura H, 2003, J HEPATOL, V38, P200, DOI 10.1016/S0168-8278(02)00360-4
  23. Kim J, 2018, AM J ROENTGENOL, V211, P1026, DOI 10.2214/AJR.18.19507
  24. Kim S, 2020, CLIN NURS RES, V29, P285, DOI 10.1177/1054773819865879
  25. Kiryu S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12688-7
  26. Kolossvary M, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.117.006843
  27. Larue RTHM, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160665
  28. Lim KC, 2011, ANN SURG, V254, P108, DOI 10.1097/SLA.0b013e31821ad884
  29. Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145
  30. Lubner MG, 2017, RADIOGRAPHICS, V37, P1483, DOI 10.1148/rg.2017170056
  31. Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5
  32. Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29
  33. Park HJ, 2017, AM J ROENTGENOL, V209, pW211, DOI 10.2214/AJR.16.17398
  34. Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
  35. Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087
  36. Peng J, 2018, DIAGN INTERV RADIOL, V24, P121, DOI 10.5152/dir.2018.17467
  37. Perrin T, 2018, ABDOM RADIOL, V43, P3271, DOI 10.1007/s00261-018-1600-6
  38. Rizzo Stefania, 2018, Eur Radiol Exp, V2, P36, DOI 10.1186/s41747-018-0068-z
  39. Rodriguez-Peralvarez M, 2013, ANN SURG ONCOL, V20, P325, DOI 10.1245/s10434-012-2513-1
  40. Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022
  41. Shan QY, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0197-5
  42. Thawani R, 2018, LUNG CANCER, V115, P34, DOI 10.1016/j.lungcan.2017.10.015
  43. Torzilli G, 1999, ARCH SURG-CHICAGO, V134, P984, DOI 10.1001/archsurg.134.9.984
  44. van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339
  45. Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05
  46. Wu JJ, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0321-9
  47. Wu M, 2018, EUR RADIOL
  48. Xu X, 2019, J HEPATOL
  49. Zheng BH, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5024-z
  50. Zheng J, 2017, J AM COLL SURGEONS, V225, P778, DOI 10.1016/j.jamcollsurg.2017.09.003
  51. Zhou W, 2017, J MAGN RESON IMAGING, V45, P1476, DOI 10.1002/jmri.25454
  52. Zhou Y, 2017, ABDOM RADIOL, V42, P1695, DOI 10.1007/s00261-017-1072-0

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - HU
Artigos e Materiais de Revistas Científicas - ODS/03